FDC vs KILITCH: Stock Comparison

FDC Limited vs Kilitch Drugs (India) Limited

Live data: 22 July 2026, 3:02 PM IST • Source: NSE and company filings

FDC Limited is the larger company by market capitalisation. FDC Limited shows a higher ROE, a higher dividend yield and lower leverage, while Kilitch Drugs (India) Limited shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of FDC Limited and Kilitch Drugs (India) Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FDC is more favourable on 9 of 13 scored metrics and KILITCH on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
FDC is the larger company
₹6,713 Cr vs ₹617 Cr
P/E Ratio
KILITCH has a lower P/E
20.92x vs 23.94x
P/B Ratio
KILITCH has a lower P/B
2.26x vs 2.71x
EPS
FDC has higher earnings per share
₹17.3 vs ₹8.92
Dividend Yield
FDC has a higher dividend yield
2.39% vs 0%
Revenue Growth (TTM YoY)
KILITCH has faster revenue growth
46.3% vs 18.9%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs 26.5%
Qtr Sales Growth
KILITCH has stronger quarterly sales growth
29% vs 18.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFDCKILITCH
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricFDCKILITCH
Live Price₹410.2₹196.99
Day Change-0.74%-4.15%
Volume1.33 L1.36 L
52-Week High₹527.8₹439
52-Week Low₹312.95₹117.25
Distance from 52W High-22.28%-55.13%

Valuation

MetricFDCKILITCH
Market Cap₹6,713 Cr₹617 Cr
P/E Ratio23.94x20.92x
P/B Ratio2.71x2.26x
EPS₹17.3₹8.92
Book Value₹152.62₹81.67
Dividend Yield2.39%0%

Growth

MetricFDCKILITCH
Revenue Growth (TTM YoY)18.9%46.3%
EPS Growth (TTM YoY)166.8%26.5%
Qtr Sales Growth18.9%29%
Qtr Profit Growth167%126%

Profitability & Leverage

MetricFDCKILITCH
ROE12.5%12.36%
ROCE16.7%15.7%
Net Margin12.96%12.81%
Operating Margin15.9%14%
Debt to Equity0.01x32.04x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFDCKILITCH
Promoter Holding69.66%63.77%
FII Holding1.4% 1 pp0.12% 0.12 pp
DII Holding6.31% 0.02 pp0%
Public Holding22.63% 0.98 pp36.11% 0.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FDC Limited and Kilitch Drugs (India) Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.